Virtu KCG Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Virtu KCG Holdings's NVO Position: Q2 2017 in Review
Virtu KCG Holdings reduced its Novo Nordisk (NVO) stake by 33% in Q2 2017, selling an estimated $282K and leaving 28,478 shares worth $611K. The position accounts for 0.02% of the portfolio, ranked #959.
Virtu KCG Holdings first reported a position in NVO in Q3 2013 and has held it in 16 quarters since. The position peaked at $14.3M in Q3 2013. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.
- Virtu KCG Holdings held 28,478 shares of Novo Nordisk worth $611K as of Q2 2017.
- Virtu KCG Holdings sold 13,992 Novo Nordisk shares in Q2 2017, an estimated $282K.
- Novo Nordisk made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #959 holding.
- Virtu KCG Holdings first reported a position in Novo Nordisk in Q3 2013 and has held it in 16 quarters since.
- Virtu KCG Holdings's Novo Nordisk position peaked at $14.3M in Q3 2013.
- 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.
Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.